In accordance with these in vitro findings, DDR1 and IR expression levels are strongly correlated in breast cancer specimens, and especially in cancers with aggressive characteristics, suggesting that the DDR1 - IR axis could be a valuable therapeutic target in human breast cancer. This evidence concerns the gene INSR and breast carcinoma.